1926
DOI: 10.1136/bmj.1.3416.1079
|View full text |Cite
|
Sign up to set email alerts
|

The Treatment of Post-Encephalitig Parkinsonism by Nicotine

Abstract: JUNE 26, I926] INICOTINE IN POST-ENCEPHALITIC PARKINSONISM. M J 1079The chemical character of the base may be an important factor; lard and wool-fat are both esters and both absorb well, the absorption increasing on continued rubbing, so that probably part at least of the absorption takes place through the sebaceous glands. Possibly the difference between them in the absdrption of medicament may be due to the glyceryl esters of the lard, which may assist the secretions of the glands t-o form oleates or other e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
0
1

Year Published

1928
1928
2009
2009

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(21 citation statements)
references
References 0 publications
0
20
0
1
Order By: Relevance
“…An excitatory nicotinic action of SNC neurones may be clinically relevant, since nicotine has been found to alleviate the immobility associated with Parkinson's disease (Moll, 1926), a condition that is associated with degeneration of the ascending dopamine pathways. This stimulant action of nicotine may bear directly on the epidemiological observation that Parkinsonism is less prevalent among tobacco smokers than among non-smokers (Kessler, 1973 (Domino, 1973 (Henningfield & Goldberg, 1983) as well as by rats (Cox et al, 1984 (Miller et al, 1983), and low doses of nicotine commonly increase behavioural and electrocortical indices of arousal (Domino, 1973, Clarke & Kumar, 1983a.…”
Section: Discussionmentioning
confidence: 99%
“…An excitatory nicotinic action of SNC neurones may be clinically relevant, since nicotine has been found to alleviate the immobility associated with Parkinson's disease (Moll, 1926), a condition that is associated with degeneration of the ascending dopamine pathways. This stimulant action of nicotine may bear directly on the epidemiological observation that Parkinsonism is less prevalent among tobacco smokers than among non-smokers (Kessler, 1973 (Domino, 1973 (Henningfield & Goldberg, 1983) as well as by rats (Cox et al, 1984 (Miller et al, 1983), and low doses of nicotine commonly increase behavioural and electrocortical indices of arousal (Domino, 1973, Clarke & Kumar, 1983a.…”
Section: Discussionmentioning
confidence: 99%
“…The temperature-dependency of nicotine-DA interactions in the striatum as well as our ®ndings that more than one kind of nicotinic AChR might mediate nicotine's eects on striatal DA are of importance considering attempts to develop nicotine analogues to treat neurodegenerative disorders, for example Parkinson's disease (Holladay et al, 1997). Already in the 1920s, nicotine was found to alleviate the immobility associated with postencephalitic parkinsonism (Moll, 1926). Further, in epidemiological studies, a negative association between parkinsonism and cigarette smoking has been consistently found (Kessler, 1973;Baron, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…It is also of interest that nicotine was tested in an early study for the treatment of postencephalitic parkinsonism (Moll 1926). The demonstration of protective actions of (-)nicotine against mechanically induced degeneration of the mesostriatal dopamine (DA) system in the male Sprague-Dawley rat (Janson et al 1986(Janson et al , 1988aFuxe et al 1990) suggests that nicotine may be involved in establishing this negative correlation.…”
mentioning
confidence: 99%